Spots Global Cancer Trial Database for leuprolide
Every month we try and update this database with for leuprolide cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Melanoma Vaccine With Peptides and Leuprolide | NCT00254397 | Melanoma | Leuprolide GP100: 209-217(... MAGE-3 Peptide | 18 Years - | M.D. Anderson Cancer Center | |
| Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score | NCT05050084 | Prostate Adenoc... | Bicalutamide Buserelin Darolutamide Degarelix Flutamide Goserelin Histrelin Leuprolide Radiation Thera... Relugolix Triptorelin | 18 Years - | NRG Oncology | |
| Adjuvant Ovarian Suppression Plus Aromatase Inhibitor or Tamoxifen in Young Women | NCT02914158 | Breast Cancer | Goserelin Tamoxifen Aromatase Inhib... Leuprolide | - 35 Years | First Affiliated Hospital, Sun Yat-Sen University | |
| Bipolar Androgen-based Therapy for Prostate Cancer (BAT) | NCT01750398 | Recurrent Prost... | Testosterone cy... Goserelin Leuprolide | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| RElugolix VErsus LeUprolide Cardiac Trial | NCT05320406 | Biochemically R... Localized Prost... Stage I Prostat... Stage II Prosta... Stage IIA Prost... Stage IIB Prost... Stage IIC Prost... Stage III Prost... Stage IIIA Pros... Stage IIIB Pros... Stage IIIC Pros... | Radiation thera... Leuprolide Relugolix | 18 Years - | Emory University | |
| S0032, Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer | NCT00028769 | Prostate Cancer | bicalutamide estramustine etoposide flutamide goserelin leuprolide nilutamide paclitaxel | 18 Years - | SWOG Cancer Research Network | |
| Ipilimumab + Androgen Depravation Therapy in Prostate Cancer | NCT01377389 | Prostate Cancer | Ipilimumab Leuprolide Goserelin Degarelix | 18 Years - | M.D. Anderson Cancer Center | |
| Study of Abraxane Plus Hormonal Therapy as Initial Treatment of Unresectable or Metastatic Prostate Cancer | NCT00521781 | Prostatic Neopl... | Abraxane Leuprolide Bicalutamide | 18 Years - | The Methodist Hospital Research Institute | |
| External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate Cancer | NCT00388804 | Prostate Cancer | Radiation Thera... Bicalutamide Leuprolide Goserelin Flutamide Questionnaire | - | M.D. Anderson Cancer Center | |
| Randomized Study of Hormonal Regulation of Infantile Hemangioma | NCT00004436 | Hemangioma | leuprolide prednisone | 1 Month - 8 Months | FDA Office of Orphan Products Development | |
| Sunitinib Malate, Hormone Ablation and Radiation Therapy in Patients With Prostate Cancer | NCT00631527 | Prostate Cancer | Leuprolide Goserelin Sunitinib Malat... Casodex Radiation Thera... | 18 Years - | M.D. Anderson Cancer Center | |
| Prediction of the PRONOUNCE Prostate Cancer Trial in Healthcare Claims Data | NCT04897958 | Prostate Cancer | Degarelix Leuprolide | - | Brigham and Women's Hospital | |
| Phase II Study of Subcutaneous Injection Depot of Leuprolide Acetate in Patient With Prostate Cancer | NCT02212197 | Prostate Cancer | leuprolide acet... leuprolide acet... | 40 Years - 85 Years | Camurus AB | |
| Bipolar Androgen-based Therapy for Prostate Cancer (BAT) | NCT01750398 | Recurrent Prost... | Testosterone cy... Goserelin Leuprolide | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Prediction of the PRONOUNCE Prostate Cancer Trial in Healthcare Claims Data | NCT04897958 | Prostate Cancer | Degarelix Leuprolide | - | Brigham and Women's Hospital | |
| Adjuvant Ovarian Suppression Plus Aromatase Inhibitor or Tamoxifen in Young Women | NCT02914158 | Breast Cancer | Goserelin Tamoxifen Aromatase Inhib... Leuprolide | - 35 Years | First Affiliated Hospital, Sun Yat-Sen University | |
| Effect of Short Term Ovarian Suppression on Androgen Overproduction in Overweight Girls With Androgen Excess | NCT01422096 | Hyperandrogenem... Obesity Polycystic Ovar... | Leuprolide | 7 Years - 18 Years | University of Virginia | |
| Study of Enzalutamide (Formerly MDV3100) as a Neoadjuvant Therapy for Patients Undergoing Prostatectomy for Localized Prostate Cancer | NCT01547299 | Prostate Cancer | Enzalutamide Leuprolide Dutasteride | 18 Years - | Pfizer | |
| Effects of Relugolix vs Leuprolide on Cardiac Function in Patients With Prostate Cancer | NCT06330805 | Prostate Adenoc... Stage IIB Prost... Stage IIC Prost... | Biospecimen Col... Contrast Agent Leuprolide Magnetic Resona... Physical Perfor... Relugolix | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Systemic and Tumor-Directed Therapy for Oligometastatic Prostate Cancer | NCT03298087 | Newly Diagnosed... | radical prostat... stereotactic bo... Leuprolide apalutamide abiraterone | 18 Years - | VA Office of Research and Development | |
| AASUR in High Risk Prostate Cancer | NCT02772588 | Prostate Cancer | ARN-509 Abiraterone Leuprolide stereotactic, u... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer | NCT03009981 | Prostate Cancer | Apalutamide LHRH Analogue Abiraterone Ace... Prednisone | 18 Years - | Alliance Foundation Trials, LLC. | |
| Sunitinib Malate With Hormonal Ablation for Patients Who Will Have Prostatectomy | NCT00329043 | Prostate Cancer | LHRH Agonist Sunitinib Malat... Radical Prostat... | - | M.D. Anderson Cancer Center | |
| Sunitinib Malate With Hormonal Ablation for Patients Who Will Have Prostatectomy | NCT00329043 | Prostate Cancer | LHRH Agonist Sunitinib Malat... Radical Prostat... | - | M.D. Anderson Cancer Center | |
| Extended Endocrine Therapy for Premenopausal Women With Breast Cancer | NCT00903162 | Breast Cancer | leuprolide letrozole zoledronic acid | 18 Years - | Dana-Farber Cancer Institute | |
| Randomized Study of Hormonal Regulation of Infantile Hemangioma | NCT00004436 | Hemangioma | leuprolide prednisone | 1 Month - 8 Months | FDA Office of Orphan Products Development | |
| Phase II Study of Subcutaneous Injection Depot of Leuprolide Acetate in Patient With Prostate Cancer | NCT02212197 | Prostate Cancer | leuprolide acet... leuprolide acet... | 40 Years - 85 Years | Camurus AB | |
| Micro RNAs to Predict Response to Androgen Deprivation Therapy | NCT02366494 | Prostate Cancer | Bicalutamide Leuprolide Goserelin Triptorelin Docetaxel Abiraterone Apalutamide Enzalutamide | 21 Years - 85 Years | Medical College of Wisconsin | |
| RecoverPC: Relugolix vs GnRH Agonist in Quality of Life | NCT05765500 | Prostate Cancer Prostatic Neopl... | Relugolix Leuprolide | 18 Years - | Dana-Farber Cancer Institute | |
| Study of Abraxane Plus Hormonal Therapy as Initial Treatment of Unresectable or Metastatic Prostate Cancer | NCT00521781 | Prostatic Neopl... | Abraxane Leuprolide Bicalutamide | 18 Years - | The Methodist Hospital Research Institute | |
| A Study of Androgen Deprivation With Leuprolide, +/- Docetaxel for Clinically Asymptomatic Prostate Cancer Participants With a Rising Prostate Specific Antigen (PSA) | NCT00514917 | Prostatic Neopl... | Docetaxel Leuprolide Bicalutamide | 18 Years - | Sanofi | |
| Stereotactic Body Radiation Therapy Plus Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy for Treatment of Metastatic, Recurrent Hormone-Sensitive Prostate Cancer, DIVINE Trial | NCT06378866 | Recurrent Castr... Stage IVB Prost... Recurrent Prost... Castration-resi... | Abiraterone Apalutamide Biospecimen Col... Bone Scan Computed Tomogr... Darolutamide Degarelix Enzalutamide Goserelin Histrelin Leuprolide Magnetic Resona... Patient Observa... Positron Emissi... Prednisone Questionnaire A... Relugolix Stereotactic Bo... Triptorelin | 18 Years - | Mayo Clinic | |
| Stereotactic Boost and Long-Term Androgen Deprivation for Adenocarcinoma of the Prostate | NCT02064036 | Adenocarcinoma ... | Stereotactic Ra... Casodex Leuprolide | 18 Years - | University of California, Davis | |
| A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer | NCT03009981 | Prostate Cancer | Apalutamide LHRH Analogue Abiraterone Ace... Prednisone | 18 Years - | Alliance Foundation Trials, LLC. | |
| Trial of Radiotherapy With Leuprolide and Enzalutamide in High Risk Prostate Cancer | NCT02508636 | Prostatic Neopl... Pelvic Nodal | Enzalutamide Leuprolide Intensity-Modul... | 18 Years - | University of California, San Francisco | |
| Trial of Radiotherapy With Leuprolide and Enzalutamide in High Risk Prostate Cancer | NCT02508636 | Prostatic Neopl... Pelvic Nodal | Enzalutamide Leuprolide Intensity-Modul... | 18 Years - | University of California, San Francisco | |
| Effect of Short Term Ovarian Suppression on Androgen Overproduction in Overweight Girls With Androgen Excess | NCT01422096 | Hyperandrogenem... Obesity Polycystic Ovar... | Leuprolide | 7 Years - 18 Years | University of Virginia | |
| A Study of Degarelix in Patients With Prostate Cancer | NCT00928434 | Prostate Cancer | Degarelix Degarelix Leuprolide | 18 Years - | Ferring Pharmaceuticals | |
| Ipilimumab + Androgen Depravation Therapy in Prostate Cancer | NCT01377389 | Prostate Cancer | Ipilimumab Leuprolide Goserelin Degarelix | 18 Years - | M.D. Anderson Cancer Center | |
| Neoadjuvant And Adjuvant Abiraterone Acetate + Apalutamide Prostate Cancer Undergoing Prostatectomy | NCT02903368 | Prostate Cancer | Apalutamide Leuprolide Prednisone Abiraterone Ace... | 18 Years - | Dana-Farber Cancer Institute | |
| Clinical Trial for Prostate Cancer | NCT00076531 | Prostate Cancer | Leuprolide Acet... | 40 Years - | Oakwood Laboratories, LLC | |
| Study of a 6-Month Sustained-Release Formulation of Leuprolide Acetate in Prostate Cancer | NCT00056654 | Prostatic Neopl... | Leuprolide acet... | - | Abbott | |
| A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease | NCT02663908 | Prostate Cancer | Degarelix Leuprolide | - | Ferring Pharmaceuticals | |
| RElugolix VErsus LeUprolide Cardiac Trial | NCT05320406 | Biochemically R... Localized Prost... Stage I Prostat... Stage II Prosta... Stage IIA Prost... Stage IIB Prost... Stage IIC Prost... Stage III Prost... Stage IIIA Pros... Stage IIIB Pros... Stage IIIC Pros... | Radiation thera... Leuprolide Relugolix | 18 Years - | Emory University | |
| Hormonal Ablation, Imatinib Mesylate and Docetaxel for Patients With Prostate Cancer | NCT00500110 | Prostate Cancer | Docetaxel Imatinib Mesyla... Leuprolide Goserelin Aceta... | - | M.D. Anderson Cancer Center | |
| Systemic and Tumor-Directed Therapy for Oligometastatic Prostate Cancer | NCT03298087 | Newly Diagnosed... | radical prostat... stereotactic bo... Leuprolide apalutamide abiraterone | 18 Years - | VA Office of Research and Development | |
| External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate Cancer | NCT00388804 | Prostate Cancer | Radiation Thera... Bicalutamide Leuprolide Goserelin Flutamide Questionnaire | - | M.D. Anderson Cancer Center | |
| Effects of Relugolix vs Leuprolide on Cardiac Function in Patients With Prostate Cancer | NCT06330805 | Prostate Adenoc... Stage IIB Prost... Stage IIC Prost... | Biospecimen Col... Contrast Agent Leuprolide Magnetic Resona... Physical Perfor... Relugolix | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone Acetate in Male Participants With Prostate Cancer | NCT00924469 | Prostate Cancer | Abiraterone Leuprolide Prednisone | 18 Years - | Janssen Research & Development, LLC |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
